Novel MRI technique improves treatment for severe depression
Using MRI and tracking to guide the delivery of magnetic stimulation to the brains of people with severe depression will see their symptoms ease for at least 6 months.
Using MRI and tracking to guide the delivery of magnetic stimulation to the brains of people with severe depression will see their symptoms ease for at least 6 months. This could vastly improve patients' quality of life. That's according to a major clinical trial funded by an NIHR and Medical Research Council (MRC) partnership.
The results of the BRIGhTMIND trial have been published in Nature Medicine. They found that on average, participants showed substantial improvements in the severity of their depression, anxiety and thinking, with better function and quality of life over 26 weeks with MRI neuronavigated Transcranial Magnetic Stimulation (TMS). This was a substantial increase on the previous reported improvements lasting only 1-3 months.
Click here to access the article.